References
- Shahidi NT. A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids. Clin. Ther.23(9), 1355–1390 (2001).
- Ebinger M, Sievers C, Ivan D, Schneider HJ, Stalla GK. Is there a neuroendocrinological rationale for testosterone as a therapeutic option in depression? J. Psychopharmacol.23(7), 841–853 (2009).
- Zarrouf FA, Artz S, Griffith J, Sirbu C, Kommor M. Testosterone and depression: systematic review and meta-analysis. J. Psychiatr. Pract.15(4), 289–305 (2009).
- Tripodianakis J, Markianos M, Rouvali O, Istikoglou C. Gonadal axis hormones in psychiatric male patients after a suicide attempt. Eur. Arch. Psychiatry Clin. Neurosci.257(3), 135–139 (2007).
- Markianos M, Tripodianakis J, Istikoglou C et al. Suicide attempt by jumping: a study of gonadal axis hormones in male suicide attempters versus men who fell by accident. Psychiatry Res.170(1), 82–85 (2009).
- Perez-Rodriguez MM, Lopez-Castroman J, Martinez-Vigo M et al. Lack of association between testosterone and suicide attempts. Neuropsychobiology63(2), 125–130 (2011).
- Butterfield MI, Stechuchak KM, Connor KM et al. Neuroactive steroids and suicidality in posttraumatic stress disorder. Am. J. Psychiatry162(2), 380–382 (2005).
- Pope HG Jr, Cohane GH, Kanayama G, Siegel AJ, Hudson JI. Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am. J. Psychiatry160(1), 105–111 (2003).
- Barrett-Connor E, Von Mühlen DG, Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study. J. Clin. Endocrinol. Metab.84(2), 573–577 (1999).
- Pope HG Jr, Katz DL. Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. Arch. Gen. Psychiatry51(5), 375–382 (1994).
- Sher L, Oquendo MA, Mann JJ. Risk of suicide in mood disorders. Clin. Neurosci. Res.1(5), 337–344 (2001).
- Chu LW, Tam S, Wong RL, Yik PY et al. Bioavailable testosterone predicts a lower risk of Alzheimer’s disease in older men. J. Alzheimers Dis.21(4), 1335–1345 (2010).
- Thilers PP, Macdonald SW, Herlitz A. The association between endogenous free testosterone and cognitive performance: a population-based study in 35 to 90 year-old men and women. Psychoneuroendocrinology31(5), 565–576 (2006).
- Sher L. Possible link between cognitive dysfunction and suicidal behavior in individuals with alcohol use disorders. Int. J. Disabil. Hum. Dev.6(2), 149–152 (2007).
- Gustavsson G, Träskman-Bendz L, Higley JD, Westrin A. CSF testosterone in 43 male suicide attempters. Eur. Neuropsychopharmacol.13(2), 105–109 (2003).
- Virkkunen M, Kallio E, Rawlings R et al. Personality profiles and state aggressiveness in Finnish alcoholic, violent offenders, fire setters, and healthy volunteers. Arch. Gen. Psychiatry51(1), 28–33 (1994).
- Olweus D, Mattsson A, Schalling D, Löw H. Circulating testosterone levels and aggression in adolescent males: a causal analysis. Psychosom. Med.50(3), 261–272 (1988).
- Engström G, Persson B, Levander S. Temperament traits in male suicide attempters and violent offenders. Eur. Psychiatry14(5), 278–283 (1999).
- Sher L, Oquendo MA, Galfalvy HC et al. The relationship of aggression to suicidal behavior in depressed patients with a history of alcoholism. Addict. Behav.30(6), 1144–1153 (2005).
- Kanayama G, Amiaz R, Seidman S, Pope HG Jr. Testosterone supplementation for depressed men: current research and suggested treatment guidelines. Exp. Clin. Psychopharmacol.15(6), 529–538 (2007).